GLP-1s are approved for weight loss in adults who have a body mass index of 30 or higher, and those who are overweight with a body mass index of 27 or higher with at least one weight-related health condition such as high blood pressure, high cholesterol and type 2 diabetes
clinicians, and follows HIPAA-compliant telehealth standards throughout your entire treatment journey
Similarly, for kidney health, the FLOW trial demonstrated that semaglutide reduced the risk of severe kidney outcomes, including kidney failure and death, by 24% (HR 0.76, 95% CI 0.660.88)
While NAC has been studied for renal protection (contrast-induced nephropathy), dosing adjustments may be necessary in severe renal impairment, and monitoring is advisable [67][68]
Strength training twice per week, paired with daily movement like walking or yoga, can greatly enhance metabolic health
Call us today and take the first step towards a healthier, more confident you